Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome.

Autor: Trobaugh-Lotrario AD; Department of Pediatric Oncology, Providence Sacred Heart Children's Hospital, Spokane, Washington, USA., O'Neill AF; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Belmonte KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Malogolowkin MH; Division of Pediatric Hematology Oncology, University of California-Davis, Davis, California, USA., Tiao GM; Division of Pediatric and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Geller JI; Division of Pediatric Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2025 Jan; Vol. 72 (1), pp. e31389. Date of Electronic Publication: 2024 Oct 16.